Tatsuya Nishikawa Selected Research

Tatsuya Nishikawa Research Topics

12	Neoplasms (Cancer) 04/2024 - 09/2016
4	Hemorrhage 04/2024 - 01/2021
3	Venous Thrombosis (Deep-Vein Thrombosis) 04/2024 - 11/2023
3	Myocarditis (Carditis) 07/2022 - 01/2022
3	Colonic Neoplasms (Colon Cancer) 10/2021 - 01/2016
2	Lung Neoplasms (Lung Cancer) 07/2022 - 07/2022
2	Bradycardia 07/2022 - 09/2021
2	Heart Diseases (Heart Disease) 01/2021 - 07/2017
1	Venous Thromboembolism 04/2024
1	Cytokine Release Syndrome 01/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2024
1	Abdominal Pain (Pain, Abdominal) 01/2024
1	Hepatitis 01/2024
1	Cardiomyopathies (Cardiomyopathy) 09/2023
1	Second Primary Neoplasms (Neoplasms, Second) 09/2023
1	Fever (Fevers) 07/2022
1	Sick Sinus Syndrome 07/2022
1	Muscular Diseases (Myopathy) 12/2021
1	Solitary Fibrous Tumors 09/2021
1	Hypertension (High Blood Pressure) 09/2021
1	Thromboembolism 09/2021
1	Hemangiopericytoma 09/2021
1	Cardiotoxicity 05/2021
1	Hematologic Neoplasms (Hematological Malignancy) 05/2021
1	Chest Pain (Chest Pains) 05/2020
1	Multiple Myeloma 05/2020
1	Muscle Spasticity (Spastic) 05/2020
1	Spasm (Spasms) 05/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2020
1	Lymphoma (Lymphomas) 03/2020
1	Thrombosis (Thrombus) 03/2020
1	Hypertrophy 03/2020
1	Pulmonary Embolism 03/2020
1	Mediastinitis 01/2020
1	Cardiac Tamponade 01/2020
1	Fatigue 01/2020
1	Pericarditis 01/2020
1	Death (Near-Death Experience) 07/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2017
1	Heart Failure 07/2017
1	Coronary Occlusion 07/2017

3	edoxabanIBA 04/2024 - 11/2023
3	Immune Checkpoint InhibitorsIBA 07/2022 - 01/2022
2	pembrolizumabIBA 01/2024 - 07/2022
2	Tyrosine Kinase InhibitorsIBA 09/2023 - 09/2021
2	RNA (Ribonucleic Acid)IBA 10/2021 - 06/2018
1	Axitinib (AG 013736)IBA 01/2024
1	Prednisolone (Predate)FDA LinkGeneric 01/2024
1	tocilizumab (atlizumab)FDA Link 01/2024
1	TenascinIBA 09/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2021
1	FilaminsIBA 12/2021
1	pazopanib FDA Link 09/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 05/2020
1	Nitroglycerin (Dynamite)FDA LinkGeneric 05/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2020
1	Bortezomib (Velcade)FDA Link 05/2020
1	Lenalidomide (CC 5013)FDA Link 05/2020
1	osimertinibIBA 03/2020
1	LipofuscinIBA 03/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	NucleolinIBA 06/2018
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2016
1	Protein Kinases (Protein Kinase)IBA 09/2016
1	Arginine (L-Arginine)FDA Link 01/2016
1	Serine (L-Serine)FDA Link 01/2016
1	RNA Splicing FactorsIBA 01/2016

10	Therapeutics 04/2024 - 07/2017
2	Percutaneous Coronary Intervention 01/2021 - 01/2021
1	Nephrectomy 01/2024
1	Drug Tapering 01/2024
1	Drug Therapy (Chemotherapy) 09/2023
1	Hematopoietic Stem Cell Transplantation 05/2021
1	Stents 01/2021
1	Vena Cava Filters (Inferior Vena Cava Filter) 03/2020
1	Punctures 01/2020
1	Operative Surgical Procedures 01/2020
1	Secondary Prevention 07/2017
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 07/2017
1	Heart-Assist Devices 07/2017